Market Overview

Benzinga's Top Upgrades, Downgrades For June 19, 2020

Share:

Upgrades

  • SunTrust Robinson Humphrey upgraded the stock for EOG Resources Inc (NYSE: EOG) from Hold to Buy. For the first quarter, EOG Resources had an EPS of $0.55, compared to year-ago quarter EPS of $1.19. The stock has a 52-week-high of $95.29 and a 52-week-low of $27.00. EOG Resources's stock last closed at $52.93 per share.
  • Macquarie upgraded the stock for Fox Corp (NASDAQ: FOXA) from Underperform to Neutral. In the third quarter, Fox showed an EPS of $0.93, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $39.73 and a 52-week-low of $19.81. Fox's stock last closed at $29.00 per share.
  • SunTrust Robinson Humphrey upgraded the stock for Occidental Petroleum Corp (NYSE: OXY) from Hold to Buy. In the first quarter, Occidental Petroleum showed an EPS of ($0.52), compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of $54.05 and a 52-week-low of $9.00. Occidental Petroleum's stock last closed at $19.69 per share.
  • For Rayonier Advanced Materials Inc (NYSE: RYAM), B of A Securities upgraded the stock from Underperform to Buy. For the first quarter, Rayonier Advanced had an EPS of ($0.39), compared to year-ago quarter EPS of ($0.52). The stock has a 52-week-high of $6.87 and a 52-week-low of $0.90. Rayonier Advanced's stock last closed at $2.45 per share.
  • For Murphy Oil Corp (NYSE: MUR), Mizuho upgraded the stock from Underperform to Neutral. Murphy Oil earned ($0.30) in the first quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $28.12 and a 52-week-low of $4.50. Murphy Oil's stock last closed at $14.91 per share.
  • Mizuho changed the rating for Devon Energy Corp (NYSE: DVN) from Neutral to Buy. For the first quarter, Devon Energy had an EPS of $0.13, compared to year-ago quarter EPS of $0.36. The stock has a 52-week-high of $29.36 and a 52-week-low of $4.70. Devon Energy's stock last closed at $12.96 per share.
  • Goldman Sachs upgraded the stock for Dynatrace Inc (NYSE: DT) from Neutral to Buy. Interestingly, in the fourth quarter, Dynatrace's EPS was $0.11. The stock has a 52-week-high of $41.67 and a 52-week-low of $17.05. Dynatrace's stock last closed at $40.41 per share.
  • For Heritage-Crystal Clean Inc (NASDAQ: HCCI), Needham upgraded the stock from Hold to Buy. For the first quarter, Heritage-Crystal Clean had an EPS of $0.23, compared to year-ago quarter EPS of $0.00. The stock has a 52-week-high of $32.58 and a 52-week-low of $11.29. Heritage-Crystal Clean's stock last closed at $16.53 per share.
  • BMO Capital upgraded the stock for Carlisle Companies Inc (NYSE: CSL) from Market Perform to Outperform. In the first quarter, Carlisle Companies showed an EPS of $1.29, compared to $1.41 from the year-ago quarter. The stock has a 52-week-high of $169.86 and a 52-week-low of $97.55. Carlisle Companies's stock last closed at $120.09 per share.
  • For IHS Markit Ltd (NYSE: INFO), Morgan Stanley upgraded the stock from Underweight to Equal-Weight. IHS Markit earned $0.66 in the first quarter. The stock has a 52-week-high of $81.65 and a 52-week-low of $44.81. IHS Markit's stock last closed at $71.72 per share.
  • Barclays upgraded the stock for Ulta Beauty Inc (NASDAQ: ULTA) from Equal-Weight to Overweight. In the first quarter, Ulta Beauty showed an EPS of ($1.05), compared to $3.08 from the year-ago quarter. The stock has a 52-week-high of $368.83 and a 52-week-low of $124.05. Ulta Beauty's stock last closed at $218.97 per share.

 

Downgrades

  • For Briggs & Stratton Corp (NYSE: BGG), Northcoast Research downgraded the stock from Neutral to Sell. For the third quarter, Briggs & Stratton had an EPS of ($0.26), compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $10.51 and a 52-week-low of $1.50. Briggs & Stratton's stock last closed at $1.63 per share.
  • For Fulcrum Therapeutics Inc (NASDAQ: FULC), B of A Securities downgraded the stock from Buy to Neutral. In the first quarter, Fulcrum Therapeutics earned ($0.81). The stock has a 52-week-high of $22.96 and a 52-week-low of $4.37. Fulcrum Therapeutics's stock last closed at $20.51 per share.
  • Goldman Sachs changed the rating for Slack Technologies Inc (NYSE: WORK) from Neutral to Sell. In the first quarter, Slack Technologies showed an EPS of ($0.02), compared to ($0.23) from the year-ago quarter. The stock has a 52-week-high of $42.00 and a 52-week-low of $15.10. Slack Technologies's stock last closed at $34.19 per share.
  • Mizuho downgraded the stock for Concho Resources Inc (NYSE: CXO) from Buy to Neutral. In the first quarter, Concho Resources showed an EPS of $0.72, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $107.69 and a 52-week-low of $33.13. Concho Resources's stock last closed at $56.96 per share.
  • For Huntsman Corp (NYSE: HUN), Seaport Global downgraded the stock from Buy to Neutral. For the first quarter, Huntsman had an EPS of $0.29, compared to year-ago quarter EPS of $0.46. The stock has a 52-week-high of $24.90 and a 52-week-low of $12.23. Huntsman's stock last closed at $18.30 per share.

 

Initiations

  • Canaccord Genuity initiated coverage on 1Life Healthcare Inc (NASDAQ: ONEM) with a Buy rating. The price target for 1Life Healthcare is set at $39.00. 1Life Healthcare earned ($0.40) in the first quarter. The stock has a 52-week-high of $42.00 and a 52-week-low of $15.00. 1Life Healthcare's stock last closed at $32.46 per share.
  • With a rating of Buy, Jefferies initiated coverage on Pluristem Therapeutics Inc (NASDAQ: PSTI). The price target is set at $12.00 for Pluristem Therapeutics. For the third quarter, Pluristem Therapeutics had an EPS of ($0.42), compared to year-ago quarter EPS of ($0.09). The stock has a 52-week-high of $13.29 and a 52-week-low of $0.40. Pluristem Therapeutics's stock last closed at $7.37 per share.
  • With a rating of Buy, Citigroup initiated coverage on Nomad Foods Ltd (NYSE: NOMD). The price target is set at $26.00 for Nomad Foods. Nomad Foods earned $0.36 in the first quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $23.06 and a 52-week-low of $14.08. Nomad Foods's stock last closed at $21.62 per share.
  • Atlantic Equities initiated coverage on Martin Marietta Materials Inc (NYSE: MLM) with an Overweight rating. The price target for Martin Marietta Materials is set at $250.00. Martin Marietta Materials earned $0.41 in the first quarter, compared to $0.68 in the year-ago quarter. The stock has a 52-week-high of $281.82 and a 52-week-low of $135.08. Martin Marietta Materials's stock last closed at $211.92 per share.
  • With a rating of Buy, Stifel initiated coverage on National Fuel Gas Co (NYSE: NFG). The price target is set at $47.00 for National Fuel Gas. National Fuel Gas earned $0.97 in the second quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $54.92 and a 52-week-low of $31.58. National Fuel Gas's stock last closed at $41.58 per share.
  • With a rating of Outperform, Oppenheimer initiated coverage on Raven Industries Inc (NASDAQ: RAVN). The price target is set at $27.00 for Raven Industries. In the first quarter, Raven Industries showed an EPS of $0.19, compared to $0.33 from the year-ago quarter. The stock has a 52-week-high of $38.00 and a 52-week-low of $16.01. Raven Industries's stock last closed at $20.89 per share.
  • With a rating of Overweight, Atlantic Equities initiated coverage on Vulcan Materials Co (NYSE: VMC). The price target is set at $145.00 for Vulcan Materials. Vulcan Materials earned $0.47 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $152.49 and a 52-week-low of $65.56. Vulcan Materials's stock last closed at $120.98 per share.
  • Jefferies initiated coverage on ZIOPHARM Oncology Inc (NASDAQ: ZIOP) with a Buy rating. The price target for ZIOPHARM Oncology is set at $7.00. For the first quarter, ZIOPHARM Oncology had an EPS of ($0.09), compared to year-ago quarter EPS of ($0.08). The stock has a 52-week-high of $7.25 and a 52-week-low of $1.79. ZIOPHARM Oncology's stock last closed at $3.29 per share.
 

Related Articles (BGG + CSL)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
ZZZScotiaBankMaintains27.0
FSVScotiaBankMaintains128.0
FNScotiaBankMaintains38.0
CSUScotiaBankMaintains1,600.0
CXOScotiaBankDowngrades43.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com